Seladelpar Lysine

Overview

Seladelpar Lysine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3989960).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Seladelpar Lysine expires 19 Mar 2035 and exclusivity 14 Aug 2031. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(2S)-2,6-diaminohexanoic acid;2-[4-[(2R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methylphenoxy]acetic acid;dihydrate

Canonical SMILES

CCO[C@H](COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C.C(CCN)C[C@@H](C(=O)O)N.O.O

InChIKey

WTKSWPYGZDCUNQ-JZXFCXSPSA-N